Audentes Therapeutics, Inc. Retained Earnings
Audentes Therapeutics, Inc. had Retained Earnings of -$459.37 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-11-07
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$459.37M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$413.63M.
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$368.86M.
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$319.47M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2019-09-30 | -$459.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$413.63M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$368.86M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$319.47M 10-Q · filed 2019-11-07 |
| 2018-09-30 | -$283.88M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$247.59M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$216.22M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$190.65M 10-K · filed 2019-03-01 |
| 2017-09-30 | -$166.27M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$141.26M 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$118.53M 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$100.41M 10-K · filed 2018-03-09 |
| 2016-09-30 | -$80.73M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$65.37M 10-Q · filed 2016-09-01 |
| 2015-12-31 | -$40.74M 10-K · filed 2017-03-13 |